search
Back to results

Tablet-based Cognitive Training

Primary Purpose

Alzheimer Disease, Dementia, Mild Cognitive Impairment

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Computerized Cognitive Training
Documentaries with delayed Computerized Cognitive Training
Sponsored by
University of Bern
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Alzheimer Disease focused on measuring Alzheimer Disease, Dementia, Mild Cognitive Impairment, Cognitive Training, Serious Games

Eligibility Criteria

60 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Clinical diagnosis of Alzheimer's Disease
  • Patients with increased risk for developing dementia
  • Must be able to give their consent

Exclusion Criteria:

  • Contra-indications for MRI scanning
  • Substance abuse
  • Severe medical conditions

Sites / Locations

  • University Hospital of Old Age Psychiatry and PsychotherapyRecruiting
  • Memory Clinic ZentralschweizRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Other

Arm Label

Study Intervention

Active Control Group

Wait-List Control

Arm Description

The study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by AD. This training will be performed for three months (each day for 20 minutes). After three months this group will continue the training at home for six months and meet monthly for group sessions (i.e. booster sessions) on site.

This control study arm will watch documentaries at home for three months (each day for 20 minutes) , instead of performing the CCT and serve as active control group. This group will also train with the CCT tasks after these three months.

This control study arm will start with the CCT with a delay of three months and serve as wait-list control group.

Outcomes

Primary Outcome Measures

Change in AD specific component score
The outcome is quantified by an AD component score including measures of EM (auditory verbal learning), SM (verbal fluency, naming task) and spatial abilities (Rey-Osterrieth complex figure test). These scores will be assessed four times, before the training as well as after three, six and nine months by tablet-based cognitive tests. A short follow-up assessment will be performed after a total of 12 months which does not include primary outcome measure.

Secondary Outcome Measures

MRI functional and structural
Secondary endpoints are changes in task related brain networks (i.e. spatial ability and episodic memory) and changes in resting state networks.

Full Information

First Posted
June 24, 2020
Last Updated
November 1, 2022
Sponsor
University of Bern
search

1. Study Identification

Unique Protocol Identification Number
NCT04452864
Brief Title
Tablet-based Cognitive Training
Official Title
Can a Serious Game-based Cognitive Training Attenuate Cognitive Decline Related to Alzheimer's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
December 1, 2024 (Anticipated)
Study Completion Date
April 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Bern

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Today the therapy options for dementia due to Alzheimer's disease (AD) are limited. One recommended intervention is cognitive stimulation. We try to develop serious games as a further treatment option, also usable in pre-dementia as well as early stages of dementia and for a long period of time. The main objective of this study is to test, if the computerized-cognitive training (CCT) is able to improve the performance in a score quantifying an "AD-specific" component score. Additionally, the neurobiological effects of the training are investigated.
Detailed Description
The study intervention consists of a computer-based cognitive training, targeting the cognitive domains mostly affected by AD. This training will be performed for three months (each day for 20 minutes). After three months the intervention group will continue the training at home for six months and meet monthly for group sessions (i.e. booster sessions) on site. Primary endpoint will be the change in an "AD-specific" component score, quantified by episodic memory, semantic memory and visuospatial abilities. Secondary endpoints are changes in task related brain networks and changes in resting state networks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease, Dementia, Mild Cognitive Impairment
Keywords
Alzheimer Disease, Dementia, Mild Cognitive Impairment, Cognitive Training, Serious Games

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomly assigned to one of three study arms and conduct a Computerized Cognitive Training (CCT) at home (daily) and on site (weekly) for 10 weeks. Before and after the CCT, neuropsychological assessments will be conducted.
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
162 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Study Intervention
Arm Type
Experimental
Arm Description
The study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by AD. This training will be performed for three months (each day for 20 minutes). After three months this group will continue the training at home for six months and meet monthly for group sessions (i.e. booster sessions) on site.
Arm Title
Active Control Group
Arm Type
Active Comparator
Arm Description
This control study arm will watch documentaries at home for three months (each day for 20 minutes) , instead of performing the CCT and serve as active control group. This group will also train with the CCT tasks after these three months.
Arm Title
Wait-List Control
Arm Type
Other
Arm Description
This control study arm will start with the CCT with a delay of three months and serve as wait-list control group.
Intervention Type
Device
Intervention Name(s)
Computerized Cognitive Training
Intervention Description
The study intervention consists of a tablet-based cognitive training, targeting the cognitive domains mostly affected by Alzheimer Disease.
Intervention Type
Device
Intervention Name(s)
Documentaries with delayed Computerized Cognitive Training
Intervention Description
The active control group watches documentaries for three months before starting with the CCT.
Primary Outcome Measure Information:
Title
Change in AD specific component score
Description
The outcome is quantified by an AD component score including measures of EM (auditory verbal learning), SM (verbal fluency, naming task) and spatial abilities (Rey-Osterrieth complex figure test). These scores will be assessed four times, before the training as well as after three, six and nine months by tablet-based cognitive tests. A short follow-up assessment will be performed after a total of 12 months which does not include primary outcome measure.
Time Frame
The primary endpoint will be assessed four times, with breaks of three months in between. Primary outcome will be assessed up to 9 months.
Secondary Outcome Measure Information:
Title
MRI functional and structural
Description
Secondary endpoints are changes in task related brain networks (i.e. spatial ability and episodic memory) and changes in resting state networks.
Time Frame
Secondary endpoints will be assessed two to four times, depending on the study arm, as MRI assessments are not always performed after six and nine months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of Alzheimer's Disease Patients with increased risk for developing dementia Must be able to give their consent Exclusion Criteria: Contra-indications for MRI scanning Substance abuse Severe medical conditions
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Esther Brill, M.Sc.
Phone
+41 31 930 9634
Email
esther.brill@upd.unibe.ch
First Name & Middle Initial & Last Name or Official Title & Degree
Christine Krebs, M.Sc.
Email
christine.krebs@upd.unibe.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefan Klöppel, Prof. Dr.
Organizational Affiliation
University of Bern
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Old Age Psychiatry and Psychotherapy
City
Bern
ZIP/Postal Code
3000
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Esther Brill, M.Sc.
Phone
+41 31 930 9634
Email
esther.brill@upd.unibe.ch
Facility Name
Memory Clinic Zentralschweiz
City
Luzern
ZIP/Postal Code
6000
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna-Katharine Brem, Dr.
Phone
+41 58 856 61 72
Email
anna.brem@lups.ch

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All IPD that underlie results in a publication will be published pseudonymized in a open access data base
IPD Sharing Time Frame
IPD and any additional material will be available when data collection and analysis is completed Items will be retained for the lifetime of the repository (at least 20years)
IPD Sharing Access Criteria
According to SNF Guidelines IPD will be published in a open access data base
Citations:
PubMed Identifier
35962371
Citation
Brill E, Krebs C, Falkner M, Peter J, Henke K, Zust M, Minkova L, Brem AK, Kloppel S. Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial. BMC Psychiatry. 2022 Aug 12;22(1):552. doi: 10.1186/s12888-022-04131-7.
Results Reference
derived

Learn more about this trial

Tablet-based Cognitive Training

We'll reach out to this number within 24 hrs